SAOS-2 cancer cells and Li-Fraumeni-derived fibroblasts were engineered to express inducible p21 to levels that were similar to those induced by daunorubicin in p53-proficient MCF-7 cells [71]. The gene discussed is CDKN1A; the disease is cancer.